An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

Research Grants

STAR Horizons and Challenges in Organotypic Culture Models for Predictive Toxicology Progress Review Meeting

Date and Time

Saturday 03/11/2017 2:00PM to 10:00PM EST
Add to Calendar


The Baltimore Convention Center
1 West Pratt Street
Baltimore, MD 21201


Purpose of the Meeting: The U.S. Environmental Protection Agency, through its Science to Achieve Results (STAR) grant program, is developing in vitro cell cultures models that replicate human biological interactions within complex tissues or organs. Advancements in these microphysiological organotypic cell culture models are increasing the probability that these platforms will reduce and replace animal testing.  These Organotypic Culture Models for Predictive Toxicology (OCM-PTs) will provide toxicity testing alternatives that are more public health relevant, faster, and less costly. Robust models of organs’ and tissues’ responses to environmental chemicals will be critical to informing implementation of the Frank R. Lautenberg Chemical Safety for the 21st Century Act, the recently amended Toxic Substances Control Act.

Sessions will be held with young investigators from the OCM-PT Centers based in the:


Meeting Agenda (PDF) (2 pp, 400 K, 06/13/2017)

Mamosphere Bioreactor for Lifestage Specific Toxicology (PDF) (20pp, 2 MB, 05/18/2017)

Synthetic Hydrogels supporting 3D Mamary Duct Morphogenisis (PDF) (16pp, 3 MB, 05/19/2017)

Utilizing an Adverse Outcome Pathway Based Approach to Identify Readouts and Cellular Components for an Organotypic Breast Model (PDF) (17 pp, 2 MB, 05/19/2017)

Engineering a Human Fusion-competent Organotypic Model of Osteogenesis and Morphogenetic Fusion (PDF) (21 pp, 4 MB, 05/25/2017)

Engineering a Human Microfluidics Platform for Palate Morphogenisis (PDF) (14pp, 2 MB, 05/19/2017)

Stage-specific OCMs to Analyze Teratogen-induced Limb Defects (PDF) (19 pp, 25 MB, 05/18/2017)

Population-based Cardiotoxicity Assessment with Human Stem Cell-derived OCMs (PDF) (11 pp, 4 MB, 05/31/2017)

Synthetic Hydrogel Matrices for Assessing Angiogenesis and Vascular Toxicity (PDF) (63 pp, 10 MB, 05/31/2017)

Engineering a Human Endocardial OCM for Assessing Valvuloseptal Development (PDF) (20 pp, 13 MB, 05/31/2017)

Embryoid Body-based OCM for Cardiotoxicity Screening (PDF) (16 pp, 26 MB, 05/25/2017)

Instrumented Fetal Membrane-on-a-Chip (IFMOC) for Human Inflammatory Pathways (PDF) 16 pp, 2MB, 05/19/2017)

Classification Model of Blood-brain Barrier Development and Toxicity (PDF) (18 pp, 3MB, 05/31/2017)

An Integrated Liver-kidney Platform for Assessing Adverse Outcome Pathways (AOPs) (PDF) (12 pp, 970 K, 05/25/2017)

Agent Based Modeling of Neurovascular Unit development (PDF) (17 pp, 2 MB, 05/31/2017)

These projects are in line with EPA's Chemical Safety for Sustainability (CSS) Research Program. Improving the safe production, use, and disposal of chemicals is a major priority in support of actions to protect human health and the environment. The Agency’s CSS research program provides the decision-support tools needed to meet that priority, while advancing innovative ways to evaluate chemicals, conduct risk management, and prioritize time-critical research.

It is EPA's policy to make reasonable accommodation to persons with disabilities wishing to participate in the agency's programs and activities, pursuant to the Rehabilitation Act of 1973, 29 U.S.C. 791. Any request for accommodation should be made to Barbara Klieforth at or 202-564-7723.

Hosted By